beta-blocker

3 marketed 6 in Phase 3 1 in Phase 2

This page covers all beta-blocker drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting beta-adrenergic receptors, Beta-adrenergic receptors, beta-1 adrenergic receptor.

Targets

beta-adrenergic receptors · Beta-adrenergic receptors · beta-1 adrenergic receptor · Beta-1 adrenergic receptor · Beta-adrenergic receptor

Marketed (3)

Phase 3 pipeline (6)

Phase 2 pipeline (1)